Chandra Bhagat Pharma Limited, a active public limited company, was established on 10 March 2003 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2003PLC139534. Registered under ROC Roc Mumbai. it is listed on BSE: 542934. It has an authorized capital of ₹8.50 Cr and a paid-up capital of ₹7.55 Cr.
Formerly known as Chandra Bhagat Pharma Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹119.97 Cr and a net worth of ₹27.48 Cr. Employing 31 professional, Its leadership includes Abha Praveen Doshi (Director), Pranav Hemant Bhagat (Whole-Time Director), Ravindra Gajanan Awati (Director). Past directors included Abha Praveen Doshi, Bharatkumar Himmatlal Makati, Shreekant Krishna Shetty. It holds ₹22.82 Cr open charges and ₹41.15 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 323-F Bhagat Bhuvan Dr.Ambedkar Road Matunga (East), Mumbai, Maharashtra, 400019.
L24230MH2003PLC139534
139534
10 March 2003
₹8.50 Cr
₹7.55 Cr
Roc Mumbai
Listed (BSE: 542934)
Active
Explore comprehensive insights into Chandra Bhagat Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abha Praveen Doshi | Director | 15 Jul 2019 | Current |
| Pranav Hemant Bhagat | Whole-Time Director | 17 May 2004 | Current |
| Ravindra Gajanan Awati | Director | 31 Aug 2019 | Current |
| Hemant Chandravadan Bhagat | Managing Director | 10 Mar 2003 | Current |
| Prachi Pranav Bhagat | Cfo | 31 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 24 Aug 2017 | Past |
| Pramod Abcsdd | Director | 31 Aug 2017 | Past |
| Pramod Abcsdd | Director | 31 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Chandra Bhagat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹228,200,000.00
₹411,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jan 2025 | Canara Bank | ₹3.00 M | Open |
| 28 Oct 2020 | Axis Bank Limited | ₹3.25 Cr | Open |
| 23 Feb 2018 | Axis Bank Limited | ₹19.27 Cr | Open |
| 26 Sep 2017 | Others | ₹1.50 Cr | Satisfied |
| 11 Sep 2017 | Others | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Chandra Bhagat Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chandra Bhagat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandra Bhagat Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Chandra Bhagat Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Chandra Bhagat Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 0.30 Cr with Charge ID 101049748 was registered on 16 Jan 2025. was recorded as a recent event.
The activity A charge registered on 11 Sep 2017 via Charge ID 100130761 with Others was fully satisfied on 11 Nov 2024. was completed.
Progress on A charge with Axis Bank Limited of Rs. 19.27 Cr registered on 23 Feb 2018 with Charge ID 100162599 was modified on 28 Jun 2024. was documented.
The activity Rajni Dawani was appointed as a Company Secretary was appointed as a Company Secretary on 30 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
The CIN of Chandra Bhagat Pharma Limited is L24230MH2003PLC139534.
Chandra Bhagat Pharma Limited is headquartered at 323-F Bhagat Bhuvan Dr.Ambedkar Road Matunga (East), Mumbai, Maharashtra, 400019.
Chandra Bhagat Pharma Limited was incorporated on 10 March 2003.
The current directors of Chandra Bhagat Pharma Limited are
The primary industry of Chandra Bhagat Pharma Limited is Manufacturing.
Chandra Bhagat Pharma Limited is listed. It is listed on BSE: 542934.
The authorized capital of Chandra Bhagat Pharma Limited is ₹8.50 Cr, and the paid-up capital is ₹7.55 Cr.
The compliance status of Chandra Bhagat Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX